60 Degrees Pharmaceuticals (SXTP) Change in Inventory (2022 - 2026)
60 Degrees Pharmaceuticals (SXTP) posted quarterly Change in Inventory of $2002.0 for Q1 2026, down 99.39% year-over-year from $330474.0 in Q1 2025, and down 98.54% quarter-over-quarter from $136915.0 in Q4 2025.
60 Degrees Pharmaceuticals (SXTP) Change in Inventory (2022 - 2026) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Change in Inventory for 5 consecutive years, with $2002.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Inventory fell 99.39% year-over-year to $2002.0; the TTM figure through Mar 2026 stood at $137365.0 (down 59.34% YoY), while the FY2025 annual figure was $465837.0, up 2090.33% from the prior year.
- Change in Inventory fell to $2002.0 in Q1 2026 per SXTP's latest filing, from $136915.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $330474.0 in Q1 2025 and bottomed at -$152542.0 in Q4 2023.
- Historically, Change in Inventory has averaged $10971.7 across 5 years, with a median of -$9357.0 in 2024.
- Annual changes were most pronounced in 2023 — Change in Inventory plunged 227.76% — and 2025, when it surged 1576.65%.
- 60 Degrees Pharmaceuticals' Change in Inventory stood at -$46541.0 in 2022, then slumped by 227.76% to -$152542.0 in 2023, then jumped by 93.92% to -$9272.0 in 2024, then soared by 1576.65% to $136915.0 in 2025, then plunged by 98.54% to $2002.0 in 2026.
- Business Quant data shows SXTP's Change in Inventory at $2002.0 in Q1 2026, $136915.0 in Q4 2025, and -$27735.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | 60 Degrees Pharmaceuticals | 3.00 Mn | 1.98 Mn | 56,798.00 | -32,658.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,002.00 |
| Mar 31, 2026 | 2,002.00 |
| Dec 31, 2025 | 136,915.00 |
| Dec 31, 2025 | 136,915.00 |
| Sep 30, 2025 | -27,735.00 |
| Sep 30, 2025 | -27,735.00 |
| Jun 30, 2025 | 26,183.00 |
| Jun 30, 2025 | 26,183.00 |
| Mar 31, 2025 | 330,474.00 |
| Mar 31, 2025 | 330,474.00 |
| Dec 31, 2024 | -9,272.00 |
| Dec 31, 2024 | -9,272.00 |
| Sep 30, 2024 | 26,016.00 |
| Sep 30, 2024 | 26,016.00 |
| Jun 30, 2024 | -9,357.00 |
| Jun 30, 2024 | -9,357.00 |
| Mar 31, 2024 | -30,792.00 |
| Mar 31, 2024 | -30,792.00 |
| Dec 31, 2023 | -152,542.00 |
| Dec 31, 2023 | -152,542.00 |